VEITHsymposium: Favorable Outcomes with TCAR vs. Carotid Endarterectomy in Patients with Carotid Artery Disease
In a headline presentation, Dr. Mahmoud Malas of the University of California, San Diego School of Medicine shared updated results for the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project contemporaneously comparing TCAR to the surgical standard of care, carotid endarterectomy (CEA).
Final Results Presented during the late-breaking session at the Society for Vascular Surgery Annual Meeting
The TCAR Surveillance Project, a key initiative of the Society for Vascular Surgery’s Vascular Quality Initiative (VQI), is an open-ended registry intended to compare real-world patient outcomes between TCAR and CEA.
Key data from the SVS TCAR Surveillance Project and ROADSTER-2 study will be presented at the upcoming Society for Vascular Surgery 2019 Vascular Annual Meeting (VAM), June 12-15 at the Gaylord National Resort & Convention Center in National Harbor, Maryland.
Silk Road Medical is focused on reducing the risk of stroke by treating carotid artery disease – a condition that affects more than 4 million people in the U.S. and is estimated to be the primary cause of up to one-third of strokes.
Silk Road Medical reports multiple podium presentations at the upcoming VEITHsymposium Nov. 13-17 at the New York Hilton-Midtown will feature the company’s TransCarotid Artery Revascularization (TCAR) procedure.
Trans Carotid Artery Revascularization (TCAR) Presentations and Data at the Annual Society for Vascular Surgery Meeting Makes POSITIVE Impact
Medical Device News Magazine interviewed two leading Vascular Surgeons who presented compelling talks on Trans Carotid Artery Revascularization (TCAR) at the Annual Meeting of the Society for Vascular Surgery Meeting held June 20 – 23, 2018 in Boston, MA.
Updated TCAR Data from Silk Road Medical’s ROADSTER 1 and 2 Studies Presented at VEITHsymposium 2017
11/29/17: Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, announced multiple presentations at the 45th annual VEITHsymposium highlighting the safety and efficacy of the company's ENROUTE® Transcarotid Neuroprotection and Stent System, the first and only products specifically designed and indicated for TransCarotid Artery Revascularization (TCAR).
12Page 1 of 2